
Common pill taken by millions could ‘slash your risk of dementia and dying young'
This is none other than metformin, "the most widely prescribed drug for type 2 diabetes", according to researchers from Taipei Medical University in Taiwan.
1
They found that people who were taking the treatment were less likely to develop memory-robbing dementia or die from any cause.
The results were based on a study of 452,777 adults who were either overweight or obese, published in Diabetes, Obesity and Metabolism.
Obesity and diabetes have both been shown to up the risk of dementia.
Some studies report that diabetics have a 70 per cent higher risk of getting the condition, compared to those without diabetes.
Meanwhile, being obese between the ages of 35-65 can increase dementia risk in later-life by about 30 per cent.
Metformin is the most common treatment for type 2 diabetes, which affects over 5 million Brits, according to Diabetes UK.
The drug is also used to help prevent type 2 diabetes in people at high risk of developing it.
It works by curbing the amount of sugar pumped around the body by the liver and helping the insulin you produce work better.
"Metformin has many advantages over other diabetic drugs. It has strong glucose-lowering effects, a reliable safety profile and is relatively cheap," researchers said.
"Metformin also reduces the likelihood of dementia in patients with diabetes."
Common painkiller used for back pain ups risk of dementia by 29%, scientists warn
But some studies suggest the drug doesn't protect against dementia, as it can cause vitamin B12 deficiency, which has been linked to cognitive decline.
It could increase the risk of Alzheimer's, a type of dementia, research suggests.
"Whether metformin's beneficial effects in patients with dementia can be applied to the general population is unclear," the study authors noted.
The study included about 905,000 people in total, split evenly into two groups: metformin users and non-metformin users.
They were matched to be similar in age, health, and other factors for a fair comparison.
The metformin group had been prescribed the drug at least twice in their lives, for at least six months.
Researchers categorised study participants by their body mass index (BMI) as:
Overweight: BMI 25–29.9
Obese class I: BMI 30–34.9
Obese class II: BMI 35–39.9
Morbidly obese: BMI over 40
They followed patients for 10 years and found that those who took metformin had a lower risk of developing dementia, regardless of their BMI.
Class I and II obese patients saw the greatest reduction in risk - 8 and 4 per cent respectively, compared to people who didn't take metformin.
Manage blood sugar levels
Strictly follow a diabetes management plan, as prescribed by a healthcare professional. This includes medication, diet and exercise.
Regularly monitor blood sugar levels and manage insulin appropriately.
Adopt a healthy lifestyle
Follow a balanced diet in fruits, vegetables, whole grains, and lean protein, with limited saturated fat, sugar, and salt.
Aim for at least 150 minutes of moderate-intensity exercise per week.
Being overweight or obese can increase the risk of type 2 diabetes and other conditions linked to dementia. Weight management through diet and exercise can help mitigate these risks.
Engage in activities that challenge your mind, such as puzzles, reading, learning new skills, or socialising.
Address other risk factors
High blood pressure and cholesterol can damage blood vessels, increasing the risk of both cardiovascular disease and dementia. Regular check-ups and appropriate treatment are essential.
Excessive alcohol consumption can negatively impact brain health. Moderate drinking or abstaining from alcohol can be beneficial.
Hearing loss can contribute to cognitive decline. Addressing hearing problems through hearing aids or other interventions can help maintain cognitive function.
Seek professional guidance
Regular medical check-ups are important for monitoring overall health and identifying and addressing potential risk factors early on.
Work with your doctor, diabetes educator, or other healthcare professionals to develop a personalized plan for managing your diabetes and reducing your risk of dementia.
Researchers said the drug's ability to lower inflammation in obese patients may have something to do with this.
"Since central nervous system inflammation and neuroinflammation are crucial factors in the development and progression of neurodegenerative diseases, the anti-inflammatory and antioxidative effects of metformin are especially beneficial in patients with obesity," they wrote.
"We observed that the protective effect of metformin against dementia was consistent across all BMI categories greater than 25."
Metformin-users also had a lower risk of early death, between 28 and 26 per cent.
"This study is strong because it included a large sample of metformin users and patients with obesity and dementia, using data from more than 184 million patients worldwide," researchers said.
"The use of real-world data allows for a better understanding of how treatments perform in a heterogeneous population because the data are captured from diverse, real-life settings.
"Therefore, the findings of this study can be readily generalised to whole populations."
But they acknowledge that their study had certain limitations too, including that the dataset only covered a 10 year period, restricting researchers' ability to evaluate the long-term effects of metformin.
They concluded: "Our study findings indicate that metformin may help reduce the risk of dementia in obese patients, which could further contribute to improving all-cause mortality.
"However, further research is required to explore the mechanisms by which metformin reduces the risk of dementia."
Experts have previously suggested that using metformin to help treat dementia could cut costs.
Dr Sara Imarisio, who used to be head of research at Alzheimer's Research UK, said: 'Repurposing an existing drug used for another health condition would be a cheaper and inexpensive way to bring about a new dementia treatment.
'Diabetes is a risk factor for dementia and there is a lot of interest in the links between the two conditions."
But recent research suggests that weight-loss jabs are better at curbing dementia risk in people with type 2 diabetes than metformin.
Metformin is generally the first-line medication for type 2 diabetes, while GLP-1 receptor agonists are often used as second-line or add-on therapy when metformin is not sufficient or tolerated.
Early signs of dementia
It's not unusual for your memory to lapse a bit as you get older.
But dementia is different from 'just getting old' as it will cause noticeable - rather than gradual - changes to mental abilities and make managing everyday tasks and activities increasingly difficult.
The symptoms of dementia may be small to start with, but get worse over time.
Below are some examples of possible signs.
Memory loss
Memory loss is a key sign of dementia. This can include:
Forgetting something you were only recently told. You may ask for the same information repeatedly – for example, 'Are the doors locked?'
Putting objects in unusual places – for example, putting your house keys in the refrigerator.
Being unable to learn new tasks, like how to use a new washing machine.
Planning and decision making issues
People with dementia can have difficulty with planning and decision making. This can include:
Getting very confused when planning or thinking things through.
Struggling to stay focused on a single task.
Not making informed, careful decisions when dealing with money or looking at risks.
Finding it hard to manage regular payments, budgets or monthly bills.
Problems with language and understanding
In people with dementia, this can manifest as:
Having frequent problems finding the right word or regularly referring to objects as 'that thing'.
Finding it hard to take part in conversations.
Regularly being unable to follow what someone is saying even without distractions.
Losing sense of time and place
Dementia can cause problems with orientation, including:
Losing track of the date, season or the passage of time.
Getting lost in a place that is familiar or that should be easy to find your way around – for example, a supermarket.
Regularly being unable to follow what someone is saying even without distractions.
Problems with vision and perception
This can mean having problems making sense of what you see.
For example, having difficulty judging distances on stairs, or mistaking reflections or patterns for other objects.
Mood and behavioural changes
Finally, dementia can also make people act differently or shift their mood. This can mean:
Becoming withdrawn and losing interest in work, friends or hobbies.
Feeling unusually sad, anxious, frightened or low in confidence.
Getting easily upset at home, at work, with friends or in places that usually feel comfortable or familiar.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
8 hours ago
- Daily Mail
Chances of a stroke before age 50 may be higher in women who have had high-risk complications in pregnancy
Women who had complicated pregnancies could be more likely to have an early stroke, a study has found. High-risk complications during pregnancy is relatively uncommon in the UK – affecting just up to 10 per cent. However, figures show those who are impacted may be more likely to experience a stroke before the age of 50. Researchers in the Netherlands examined a sample of more than 1,000 women between the ages of 18 and 49, who had been pregnant at least once before. They looked at how often certain pregnancy complications had occurred in those who had strokes. These included pre-eclampsia – high blood pressure during pregnancy – pre-term birth before 37 weeks, babies born small for their gestational age, gestational diabetes, miscarriage and stillbirth. Women who had a stroke were found to be more than twice as likely to have gone through at least one pregnancy complication, while those who had previously had a stillbirth were at the highest risk of stroke, estimated to be five times more likely. Complications such as pre-eclampsia and pre-term birth were associated with strokes linked to large artery disease – often caused by a build-up of fatty deposits. 'Doctors should ask about pregnancy history when assessing stroke risk,' said the study's lead author Dr Frank-Erik de Leeuw, a professor in cerebrovascular disease at Radboud University. 'Our study suggests we may need to start thinking about cardiovascular prevention earlier in life – not just after menopause. 'Future studies should investigate the effects of lifestyle modification aimed at reducing cardiovascular risk in women with pregnancy complications.' Previous research has shown that pregnancy itself can increase a woman's stroke risk by increasing blood volume, changing blood clotting factors and altering the elasticity of her blood vessels – with the highest risk occurring in the six weeks after delivery.


Daily Mail
8 hours ago
- Daily Mail
Study finds microplastics in your tea... and posh brands are the worst culprits
With more than 100 million cuppas drunk every day, tea has long been Britain's favourite beverage. But a brew-up may just have become rather less palatable after scientists found an unpleasant hidden ingredient lurking alongside the milk, hot water and tea leaves. A study has found that a hot cup of tea made with a teabag contains traces of microplastics – tiny particles of plastic invisible to the human eye, whose effect on our health is still being investigated. They are thought to come from the bags rather than the tea leaves, because the plastic polypropylene is used to seal them and prevent them falling apart when wet. Researchers believe that when boiling water is poured on the bags they release microscopic particles of these plastics into the drink – and the bad news for tea snobs is that the most expensive brands are the worst culprits because they sometimes coat their teabags with plastics to make them feel 'silkier' and luxurious. The study is the latest to find microplastics in the food chain, including in tap and bottled water. The concern is that they can enter the body and cause harm, although the World Health Organisation says there is no convincing evidence of health effects in humans. But research has suggested that an accumulation in the body could be linked to hormone issues, weight gain and some cancers. The University of Birmingham researchers said: 'Our findings highlight the potential health risk associated with microplastic contamination in tea. 'The most expensive teabag brand showed the highest concentrations, significantly exceeding those in low-priced teabags. 'Continued exposure to microplastics through drinks may contribute to daily intakes, leading to potential adverse implications for health.' The study is thought to be the first to look at microplastic contamination of different cold and hot drinks from the same country. Experts tested 31 drinks from UK brands. None was named. Hot tea had the highest average content, with 60 microplastics per litre – 12 to 15 in a cup or a mug. This was three times as much as soft drinks, according to the study, which was published in the journal Science of the Total Environment. Tea in paper cups had among the highest levels, possibly because such cups have a plastic polyethylene coating that may degrade in hot water. Preparing tea in a glass cup decreased the risk. Hot coffee contained an average of 43 microplastics per litre, with more in a paper cup. Iced tea and coffee contained fewer microplastics. Fruit juices had an average of 30 per litre, energy drinks contained 25 and other soft drinks averaged 17. But Dr Tim Bond, of the Tea Advisory Panel, which promotes the health benefits of tea, said: 'The jury is still out on the impact of microplastics. They are everywhere – even in the air we breathe – so they can't be fully avoided.'


Daily Mail
8 hours ago
- Daily Mail
Using an air purifier at home may slash the risk of heart attacks
Using an air purifier at home may reduce the risk of heart attacks, researchers suggest. Studies have long linked air pollution to cardiovascular disease, with those most at risk tending to live near busy roads. Particles emitted from car exhaust fumes and tyre rubber can drift into nearby homes. Once inhaled, they enter the bloodstream and have been associated with an increased risk of high blood pressure, inflammation, abnormal heart rhythms and the build-up of plaque in the arteries. In the UK, the problem is said to be the number one environmental risk factor for heart and circulatory diseases – contributing to an estimated 14,000 deaths each year. But scientists at the University of Connecticut say portable air purifiers could be the solution. Researchers divided 154 adults living near highways in the US into two groups, giving one a high-efficiency particulate air (HEPA) purifier to use in their homes. The other group was given the same unit with the filter removed, leaving it unable to properly purify the air. After a month, the groups swapped purifiers. Blood pressure measurements and questionnaires were carried out at the start and end of each period. Participants who started the study with elevated blood pressure saw it reduce during the time using the HEPA filter, while those given the sham unit saw their blood pressure increase in the same period. 'This research adds to growing evidence that simple interventions, like in-home air filtration, may help improve heart health for people at risk,' said Dr Douglas Brugge, chair of the Department of Public Health Sciences at the University of Connecticut and lead author of the study. According to the British Heart Foundation, 96 per cent of people in England are exposed to air pollution levels that exceed the limits set out by the World Health Organisation, while those living in deprived areas are at a significantly greater risk.